<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34571840</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>11</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2073-4409</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>10</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Aug</Month>
              <Day>25</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cells</Title>
          <ISOAbbreviation>Cells</ISOAbbreviation>
        </Journal>
        <ArticleTitle><i>Helicobacter pylori</i> Infection and Extragastric Diseases-A Focus on the Central Nervous System.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">2191</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10092191</ELocationID>
        <Abstract>
          <AbstractText><i>Helicobacter pylori</i> (<i>H. pylori</i>) is most known to cause a wide spectrum of gastrointestinal impairments; however, an increasing number of studies indicates that <i>H. pylori</i> infection might be involved in numerous extragastric diseases such as neurological, dermatological, hematologic, ocular, cardiovascular, metabolic, hepatobiliary, or even allergic diseases. In this review, we focused on the nervous system and aimed to summarize the findings regarding <i>H. pylori</i> infection and its involvement in the induction/progression of neurological disorders. Neurological impairments induced by <i>H. pylori</i> infection are primarily due to impairments in the gut-brain axis (GBA) and to an altered gut microbiota facilitated by <i>H. pylori</i> colonization. Currently, regarding a potential relationship between <i>Helicobacter</i> infection and neurological disorders, most of the studies are mainly focused on <i>H. pylori</i>.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Baj</LastName>
            <ForeName>Jacek</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-1372-8987</Identifier>
            <AffiliationInfo>
              <Affiliation>Chair and Department of Anatomy, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Forma</LastName>
            <ForeName>Alicja</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-8714-7627</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Medical University of Lublin, 20-090 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flieger</LastName>
            <ForeName>Wojciech</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">0000-0002-0509-868X</Identifier>
            <AffiliationInfo>
              <Affiliation>Chair and Department of Anatomy, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Morawska</LastName>
            <ForeName>Izabela</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">0000-0001-9462-8779</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, 20-093 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Michalski</LastName>
            <ForeName>Adam</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-9598-373X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, 20-093 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Buszewicz</LastName>
            <ForeName>Grzegorz</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0001-7637-6387</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Medical University of Lublin, 20-090 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sitarz</LastName>
            <ForeName>Elżbieta</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Chair and I Department of Psychiatry, Psychotherapy, and Early Intervention, Medical University of Lublin, 20-439 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Portincasa</LastName>
            <ForeName>Piero</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0001-5359-1471</Identifier>
            <AffiliationInfo>
              <Affiliation>Clinica Medica "A. Murri", Department of Biomedical Sciences &amp; Human Oncology, University of Bari Medical School, 70124 Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garruti</LastName>
            <ForeName>Gabriella</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Endocrinology, Department of Emergency and Organ Transplantations, University of Bari "Aldo Moro" Medical School, Piazza G. Cesare 11, 70124 Bari, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flieger</LastName>
            <ForeName>Michał</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Medical University of Lublin, 20-090 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Teresiński</LastName>
            <ForeName>Grzegorz</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Forensic Medicine, Medical University of Lublin, 20-090 Lublin, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>08</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cells</MedlineTA>
        <NlmUniqueID>101600052</NlmUniqueID>
        <ISSNLinking>2073-4409</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016481" MajorTopicYN="N">Helicobacter Infections</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016480" MajorTopicYN="N">Helicobacter pylori</DescriptorName>
          <QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Alzheimer’s disease</Keyword>
        <Keyword MajorTopicYN="Y">Bickerstaff brainstem encephalitis</Keyword>
        <Keyword MajorTopicYN="Y">Devic syndrome</Keyword>
        <Keyword MajorTopicYN="Y">Guillain–Barré syndrome</Keyword>
        <Keyword MajorTopicYN="Y">Helicobacter pylori</Keyword>
        <Keyword MajorTopicYN="Y">Parkinson’s disease</Keyword>
        <Keyword MajorTopicYN="Y">gut–brain axis</Keyword>
        <Keyword MajorTopicYN="Y">migraine</Keyword>
        <Keyword MajorTopicYN="Y">multiple sclerosis</Keyword>
        <Keyword MajorTopicYN="Y">nervous system</Keyword>
        <Keyword MajorTopicYN="Y">stroke</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>28</Day>
          <Hour>1</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34571840</ArticleId>
        <ArticleId IdType="pmc">PMC8469861</ArticleId>
        <ArticleId IdType="doi">10.3390/cells10092191</ArticleId>
        <ArticleId IdType="pii">cells10092191</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hooi J.K.Y., Lai W.Y., Ng W.K., Suen M.M.Y., Underwood F.E., Tanyingoh D., Malfertheiner P., Graham D.Y., Wong V.W.S., Wu J.C.Y., et al.  Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017;153:420–429. doi: 10.1053/j.gastro.2017.04.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2017.04.022</ArticleId>
            <ArticleId IdType="pubmed">28456631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thung I., Aramin H., Vavinskaya V., Gupta S., Park J.Y., Crowe S.E., Valasek M.A. Review article: The global emergence of Helicobacter pylori antibiotic resistance. Aliment. Pharmacol. Ther. 2016;43:514–533. doi: 10.1111/apt.13497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apt.13497</ArticleId>
            <ArticleId IdType="pmc">PMC5064663</ArticleId>
            <ArticleId IdType="pubmed">26694080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., Sibley R.K. Helicobacter pyloriInfection and the Risk of Gastric Carcinoma. N. Engl. J. Med. 1991;325:1127–1131. doi: 10.1056/NEJM199110173251603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199110173251603</ArticleId>
            <ArticleId IdType="pubmed">1891020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suerbaum S., Michetti P. Helicobacter pylori Infection. N. Engl. J. Med. 2002;347:1175–1186. doi: 10.1056/NEJMra020542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra020542</ArticleId>
            <ArticleId IdType="pubmed">12374879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kusters J.G., van Vliet A.H.M., Kuipers E.J. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 2006;19:449–490. doi: 10.1128/CMR.00054-05.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.00054-05</ArticleId>
            <ArticleId IdType="pmc">PMC1539101</ArticleId>
            <ArticleId IdType="pubmed">16847081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunn B.E., Cohen H., Blaser M.J. Helicobacter pylori. Clin. Microbiol. Rev. 1997;10:720–741. doi: 10.1128/CMR.10.4.720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.10.4.720</ArticleId>
            <ArticleId IdType="pmc">PMC172942</ArticleId>
            <ArticleId IdType="pubmed">9336670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kayali S., Manfredi M., Gaiani F., Bianchi L., Bizzarri B., Leandro G., Di Mario F., De’Angelis G.L. Helicobacter pylori, trans-mission routes and recurrence of infection: State of the art. Acta Biomed. 2018;89:72–76. doi: 10.23750/abm.v89i8-S.7947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.23750/abm.v89i8-S.7947</ArticleId>
            <ArticleId IdType="pmc">PMC6502203</ArticleId>
            <ArticleId IdType="pubmed">30561421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown L.M. Helicobacter pylori: Epidemiology and routes of transmission. Epidemiol. Rev. 2000;22:283–297. doi: 10.1093/oxfordjournals.epirev.a018040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordjournals.epirev.a018040</ArticleId>
            <ArticleId IdType="pubmed">11218379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimola S., Caruso M.L. Helicobacter pylori in animals affecting the human habitat through the food chain. Anticancer Res. 1999;19:3889–3894.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10628327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aziz R.K., Khalifa M.M., Sharaf R.R. Contaminated water as a source of Helicobacter pylori infection: A review. J. Adv. Res. 2015;6:539–547. doi: 10.1016/j.jare.2013.07.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jare.2013.07.007</ArticleId>
            <ArticleId IdType="pmc">PMC4506966</ArticleId>
            <ArticleId IdType="pubmed">26199743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R.J. Helicobacter pyloriInfection and the Development of Gastric Cancer. N. Engl. J. Med. 2001;345:784–789. doi: 10.1056/NEJMoa001999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa001999</ArticleId>
            <ArticleId IdType="pubmed">11556297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crowe S.E. Helicobacter pylori Infection. N. Engl. J. Med. 2019;380:1158–1165. doi: 10.1056/NEJMcp1710945.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMcp1710945</ArticleId>
            <ArticleId IdType="pubmed">30893536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Machlowska J., Kapusta P., Baj J., Morsink F.H.M., Wołkow P., Maciejewski R., Offerhaus G.J.A., Sitarz R. High-Throughput Se-quencing of Gastric Cancer Patients: Unravelling Genetic Predispositions Towards an Early-Onset Subtype. Cancers. 2020;12:1981.  doi: 10.3390/cancers12071981.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers12071981</ArticleId>
            <ArticleId IdType="pmc">PMC7409326</ArticleId>
            <ArticleId IdType="pubmed">32708070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Budzyński J., Kłopocka M. Brain-gut axis in the pathogenesis of Helicobacter pylori infection. World J. Gastroenterol. 2014;20:5212–5225. doi: 10.3748/wjg.v20.i18.5212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v20.i18.5212</ArticleId>
            <ArticleId IdType="pmc">PMC4017036</ArticleId>
            <ArticleId IdType="pubmed">24833851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kountouras J., Zavos C., Polyzos S.A., Deretzi G. The gut-brain axis: Interactions between Helicobacter pylori and enteric and central nervous systems. Ann. Gastroenterol. 2015;28:506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4585404</ArticleId>
            <ArticleId IdType="pubmed">26423130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cryan J.F., O’Mahony S.M. The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterol. Motil. 2011;23:187–192. doi: 10.1111/j.1365-2982.2010.01664.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2982.2010.01664.x</ArticleId>
            <ArticleId IdType="pubmed">21303428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mulak A., Bonaz B. Brain-gut-microbiota axis in Parkinson’s disease. World J. Gastroenterol. 2015;21:10609. doi: 10.3748/wjg.v21.i37.10609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v21.i37.10609</ArticleId>
            <ArticleId IdType="pmc">PMC4588083</ArticleId>
            <ArticleId IdType="pubmed">26457021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franceschi F., Gasbarrini A., Polyzos S.A., Kountouras J. Extragastric Diseases and Helicobacter pylori. Helicobacter. 2015;20:40–46. doi: 10.1111/hel.12256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/hel.12256</ArticleId>
            <ArticleId IdType="pubmed">26372824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honjo K., van Reekum R., Verhoeff N.P.L.G. Alzheimer’s disease and infection: Do infectious agents contribute to progression of Alzheimer’s disease? Alzheimer’s Dement. 2009;5:348–360. doi: 10.1016/j.jalz.2008.12.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jalz.2008.12.001</ArticleId>
            <ArticleId IdType="pubmed">19560105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kountouras J., Tsolaki M., Gavalas E., Boziki M., Zavos C., Karatzoglou P., Chatzopoulos D., Venizelos I. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology. 2006;66:938–940. doi: 10.1212/01.wnl.0000203644.68059.5f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/01.wnl.0000203644.68059.5f</ArticleId>
            <ArticleId IdType="pubmed">16567719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gavalas E., Kountouras J., Deretzi G., Boziki M., Grigoriadis N., Zavos C., Venizelos I. Helicobacter pylori and multiple sclerosis. J. Neuroimmunol. 2007;188:187–189. doi: 10.1016/j.jneuroim.2007.06.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2007.06.007</ArticleId>
            <ArticleId IdType="pubmed">17614142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park A.M., Omura S., Fujita M., Sato F., Tsunoda I. Helicobacter pylori and gut microbiota in multiple sclerosis versus Alzheimer’s disease: 10 pitfalls of microbiome studies. Clin. Exp. Neuroimmunol. 2017;8:215–232. doi: 10.1111/cen3.12401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cen3.12401</ArticleId>
            <ArticleId IdType="pmc">PMC5693366</ArticleId>
            <ArticleId IdType="pubmed">29158778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dardiotis E., Sokratous M., Tsouris Z., Siokas V., Mentis A.A., Aloizou A.M., Michalopoulou A., Bogdanos D.P., Xiromerisiou G., Deretzi G., et al.  Association between Helicobacter pylori infection and Guillain-Barré Syndrome: A meta-analysis. Eur. J. Clin. Investig. 2020;50:e13218. doi: 10.1111/eci.13218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/eci.13218</ArticleId>
            <ArticleId IdType="pubmed">32124432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kountouras J., Deretzi G., Zavos C., Tsiptsios D., Gavalas E., Vardaka E., Polyzos S.A., Klonizakis P., Kyriakou P., Pοlyzos S.A. Helicobacter pylori infection may trigger Guillain-Barré syndrome, Fisher syndrome and Bickerstaff brainstem encephalitis. J. Neurol. Sci. 2011;305:167–168. doi: 10.1016/j.jns.2011.03.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2011.03.015</ArticleId>
            <ArticleId IdType="pubmed">21440259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum. 1994;61:1–241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7681621</ArticleId>
            <ArticleId IdType="pubmed">7715068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burucoa C., Axon A. Epidemiology of Helicobacter pylori infection. Helicobacter. 2017;22:e12403. doi: 10.1111/hel.12403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/hel.12403</ArticleId>
            <ArticleId IdType="pubmed">28891138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baj J., Korona-Głowniak I., Forma A., Maani A., Sitarz E., Rahnama-Hezavah M., Radzikowska E., Portincasa P. Mechanisms of the Epithelial–Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer. Cells. 2020;9:1055.  doi: 10.3390/cells9041055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells9041055</ArticleId>
            <ArticleId IdType="pmc">PMC7225971</ArticleId>
            <ArticleId IdType="pubmed">32340207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baj J., Brzozowska K., Forma A., Maani A., Sitarz E., Portincasa P. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis. Int. J. Mol. Sci. 2020;21:2544.  doi: 10.3390/ijms21072544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21072544</ArticleId>
            <ArticleId IdType="pmc">PMC7177728</ArticleId>
            <ArticleId IdType="pubmed">32268527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kozak J., Forma A., Czeczelewski M., Kozyra P., Sitarz E., Radzikowska-Büchner E., Sitarz M., Baj J. Inhibition or Reversal of the Epithelial-Mesenchymal Transition in Gastric Cancer: Pharmacological Approaches. Int. J. Mol. Sci. 2021;22:277.  doi: 10.3390/ijms22010277.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22010277</ArticleId>
            <ArticleId IdType="pmc">PMC7795012</ArticleId>
            <ArticleId IdType="pubmed">33383973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baj J., Forma A., Sitarz M., Portincasa P., Garruti G., Krasowska D., Maciejewski R. Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment. Cells. 2020;10:27.  doi: 10.3390/cells10010027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells10010027</ArticleId>
            <ArticleId IdType="pmc">PMC7824444</ArticleId>
            <ArticleId IdType="pubmed">33375694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Z., Maqbool J., Sajid F., Hussain G., Sun T. Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases. Microb. Pathog. 2021;150:104675. doi: 10.1016/j.micpath.2020.104675.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.micpath.2020.104675</ArticleId>
            <ArticleId IdType="pubmed">33352217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collins S.M., Surette M., Bercik P. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 2012;10:735–742. doi: 10.1038/nrmicro2876.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro2876</ArticleId>
            <ArticleId IdType="pubmed">23000955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharkey K.A., Beck P.L., McKay D.M. Neuroimmunophysiology of the gut: Advances and emerging concepts focusing on the epithelium. Nat. Rev. Gastroenterol. Hepatol. 2018;15:765–784. doi: 10.1038/s41575-018-0051-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41575-018-0051-4</ArticleId>
            <ArticleId IdType="pubmed">30069036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cryan J.F., O’Riordan K.J., Cowan C.S., Sandhu K.V., Bastiaanssen T.F., Boehme M., Codagnone M.G., Cussotto S., Fulling C., Golubeva A.V., et al.  The microbiota-gut-brain axis. Physiol. Rev. 2019;99:1877–2013. doi: 10.1152/physrev.00018.2018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00018.2018</ArticleId>
            <ArticleId IdType="pubmed">31460832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udit S., Gautron L. Molecular anatomy of the gut-brain axis revealed with transgenic technologies: Implications in metabolic research. Front. Neurosci. 2013;7:134. doi: 10.3389/fnins.2013.00134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2013.00134</ArticleId>
            <ArticleId IdType="pmc">PMC3728986</ArticleId>
            <ArticleId IdType="pubmed">23914153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hattori N., Yamashiro Y. The Gut-Brain Axis. Ann. Nutr. Metab. 2021:1–3. doi: 10.1159/000512226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000512226</ArticleId>
            <ArticleId IdType="pubmed">33406517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forsythe P., Kunze W.A. Voices from within: Gut microbes and the CNS. Cell. Mol. Life Sci. 2013;70:55–69. doi: 10.1007/s00018-012-1028-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-012-1028-z</ArticleId>
            <ArticleId IdType="pubmed">22638926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayer E.A., Tillisch K., Gupta A. Gut/brain axis and the microbiota. J. Clin. Investig. 2015;125:926–938. doi: 10.1172/JCI76304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI76304</ArticleId>
            <ArticleId IdType="pmc">PMC4362231</ArticleId>
            <ArticleId IdType="pubmed">25689247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delvaux M. Alterations of sensori-motor functions of the digestive tract in the pathophysiology of irritable bowel syndrome. Best Pract. Res. Clin. Gastroenterol. 2004;18:747–771. doi: 10.1016/j.bpg.2004.06.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bpg.2004.06.004</ArticleId>
            <ArticleId IdType="pubmed">15324712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fasano A., Shea-Donohue T. Mechanisms of disease: The role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2005;2:416–422. doi: 10.1038/ncpgasthep0259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncpgasthep0259</ArticleId>
            <ArticleId IdType="pubmed">16265432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wehrwein E.A., Orer H.S., Barman S.M.  Comprehensive Physiology. Volume 6. John Wiley &amp; Sons, Inc.; Hoboken, NJ, USA: 2016. Overview of the Anatomy, Physiology, and Pharmacology of the Autonomic Nervous System; pp. 1239–1278.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cphy.c150037</ArticleId>
            <ArticleId IdType="pubmed">27347892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonaz B.L., Bernstein C.N. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 2013;144:36–49. doi: 10.1053/j.gastro.2012.10.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2012.10.003</ArticleId>
            <ArticleId IdType="pubmed">23063970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grenham S., Clarke G., Cryan J.F., Dinan T.G. Brain-gut-microbe communication in health and disease. Front. Physiol. 2011;2:94. doi: 10.3389/fphys.2011.00094.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2011.00094</ArticleId>
            <ArticleId IdType="pmc">PMC3232439</ArticleId>
            <ArticleId IdType="pubmed">22162969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dinan T.G., Quigley E.M., Ahmed S.M., Scully P., O’Brien S., O’Mahony L., Mahony S.O., Shanahan F., Keeling P.N. Hypothalamic-Pituitary-Gut Axis Dysregulation in Irritable Bowel Syndrome: Plasma Cytokines as a Potential Biomarker? Gastroenterology. 2006;130:304–311. doi: 10.1053/j.gastro.2005.11.033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2005.11.033</ArticleId>
            <ArticleId IdType="pubmed">16472586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clarke G., Grenham S., Scully P., Fitzgerald P.J., Moloney R.D., Shanahan F., Dinan T., Cryan J. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry. 2012;18:666–673. doi: 10.1038/mp.2012.77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2012.77</ArticleId>
            <ArticleId IdType="pubmed">22688187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sgambato D., Capuano A., Sullo M.G., Miranda A., Federico A., Romano M. Gut-Brain Axis in Gastric Mucosal Damage and Protection. Curr. Neuropharmacol. 2016;14:959–966. doi: 10.2174/1570159X14666160223120742.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1570159X14666160223120742</ArticleId>
            <ArticleId IdType="pmc">PMC5333589</ArticleId>
            <ArticleId IdType="pubmed">26903151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pott J., Hornef M. Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Repo. 2012;13:684–698. doi: 10.1038/embor.2012.96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/embor.2012.96</ArticleId>
            <ArticleId IdType="pmc">PMC3410395</ArticleId>
            <ArticleId IdType="pubmed">22801555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cani P.D., Everard A., Duparc T. Gut microbiota, enteroendocrine functions and metabolism. Curr. Opin. Pharmacol. 2013;13:935–940. doi: 10.1016/j.coph.2013.09.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.coph.2013.09.008</ArticleId>
            <ArticleId IdType="pubmed">24075718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reigstad C.S., Salmonson C.E., Iii J.F.R., Szurszewski J.H., Linden D.R., Sonnenburg J.L., Farrugia G., Kashyap P.C. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. 2014;29:1395–1403. doi: 10.1096/fj.14-259598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.14-259598</ArticleId>
            <ArticleId IdType="pmc">PMC4396604</ArticleId>
            <ArticleId IdType="pubmed">25550456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strandwitz P., Kim K.H., Terekhova D., Liu J.K., Sharma A., Levering J., McDonald D., Dietrich D., Ramadhar T.R., Lekbua A., et al.  GABA-modulating bacteria of the human gut microbiota. Nat. Microbiol. 2018;4:396–403. doi: 10.1038/s41564-018-0307-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41564-018-0307-3</ArticleId>
            <ArticleId IdType="pmc">PMC6384127</ArticleId>
            <ArticleId IdType="pubmed">30531975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhee S.H., Pothoulakis C., Mayer E.A. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 2009;6:306–314. doi: 10.1038/nrgastro.2009.35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrgastro.2009.35</ArticleId>
            <ArticleId IdType="pmc">PMC3817714</ArticleId>
            <ArticleId IdType="pubmed">19404271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaelberer M.M., Buchanan K.L., Klein M.E., Barth B.B., Montoya M.M., Shen X., Bohórquez D.V. A gut-brain neural circuit for nutrient sensory transduction. Science. 2018;361:eaat5236. doi: 10.1126/science.aat5236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.aat5236</ArticleId>
            <ArticleId IdType="pmc">PMC6417812</ArticleId>
            <ArticleId IdType="pubmed">30237325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berthoud H.R., Blackshaw L.A., Brookes S.J.H., Grundy D. Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol. Motil. 2004;16((Suppl. S1)):28–33. doi: 10.1111/j.1743-3150.2004.00471.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1743-3150.2004.00471.x</ArticleId>
            <ArticleId IdType="pubmed">15066001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pavlov V.A., Tracey K.J. The cholinergic anti-inflammatory pathway. Brain Behav. Immunity. 2005;19:493–499. doi: 10.1016/j.bbi.2005.03.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbi.2005.03.015</ArticleId>
            <ArticleId IdType="pubmed">15922555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Browning J.S., Houseworth J.H. Development of new symptoms following medical and surgical treatment for duodenal ulcer. Psychosom. Med. 1953;15:328–336. doi: 10.1097/00006842-195307000-00006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006842-195307000-00006</ArticleId>
            <ArticleId IdType="pubmed">13074448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whitlock F.A. Some psychiatric consequences of gastrectomy. Br. Med. J. 1961;1:1560–1564. doi: 10.1136/bmj.1.5239.1560.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.1.5239.1560</ArticleId>
            <ArticleId IdType="pmc">PMC1954208</ArticleId>
            <ArticleId IdType="pubmed">13784913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grimonprez A., Raedt R., Baeken C., Boon P., Vonck K. The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies. Neurosci. Biobehav. Rev. 2015;56:26–34. doi: 10.1016/j.neubiorev.2015.06.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2015.06.019</ArticleId>
            <ArticleId IdType="pubmed">26116875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spichak S., Bastiaanssen T.F., Berding K., Vlckova K., Clarke G., Dinan T.G., Cryan J.F. Mining microbes for mental health: Determining the role of microbial metabolic pathways in human brain health and disease. Neurosci. Biobehav. Rev. 2021;125:698–761. doi: 10.1016/j.neubiorev.2021.02.044.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2021.02.044</ArticleId>
            <ArticleId IdType="pubmed">33675857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson G., Rodriguez M., Reiter R.J. Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells. Int. J. Mol. Sci. 2019;20:5500.  doi: 10.3390/ijms20215500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms20215500</ArticleId>
            <ArticleId IdType="pmc">PMC6862663</ArticleId>
            <ArticleId IdType="pubmed">31694154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boziki M., Grigoriadis N., Papaefthymiou A., Doulberis M., Polyzos S.A., Gavalas E., Deretzi G., Karafoulidou E., Kesidou E., Taloumtzis C., et al.  The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis. Neurochem. Int. 2021;144:104938. doi: 10.1016/j.neuint.2020.104938.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuint.2020.104938</ArticleId>
            <ArticleId IdType="pubmed">33535070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engelhardt B., Liebner S. Novel insights into the development and maintenance of the blood-brain barrier. Cell Tissue Res. 2014;355:687–699. doi: 10.1007/s00441-014-1811-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00441-014-1811-2</ArticleId>
            <ArticleId IdType="pmc">PMC3972432</ArticleId>
            <ArticleId IdType="pubmed">24590145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bacon C.M., Du M.Q., Dogan A. Mucosa-associated lymphoid tissue (MALT) lymphoma: A practical guide for pathologists. J Clin Pathol. 2007;60:361–372. doi: 10.1136/jcp.2005.031146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jcp.2005.031146</ArticleId>
            <ArticleId IdType="pmc">PMC2001121</ArticleId>
            <ArticleId IdType="pubmed">16950858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayer E.A., Tillisch K., Bradesi S. Review article: Modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment. Pharmacol. Ther. 2006;24:919–933. doi: 10.1111/j.1365-2036.2006.03078.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2036.2006.03078.x</ArticleId>
            <ArticleId IdType="pubmed">16948804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sticlaru L., Stăniceanu F., Cioplea M., Nichita L., Bastian A., Micu G., Popp C. Dangerous Liaison: Helicobacter pylori, Ganglionitis, and Myenteric Gastric Neurons: A Histopathological Study. Anal. Cell. Pathol. (Amst.) 2019;2019:3085181. doi: 10.1155/2019/3085181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2019/3085181</ArticleId>
            <ArticleId IdType="pmc">PMC7012220</ArticleId>
            <ArticleId IdType="pubmed">32082967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gravina A.G., Zagari R.M., De Musis C., Romano L., Loguercio C., Romano M. Helicobacter pylori and extragastric diseases: A review. World J. Gastroenterol. 2018;24:3204–3221. doi: 10.3748/wjg.v24.i29.3204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v24.i29.3204</ArticleId>
            <ArticleId IdType="pmc">PMC6079286</ArticleId>
            <ArticleId IdType="pubmed">30090002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carabotti M., Scirocco A., Maselli M.A., Severi C. The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. 2015;28:203–209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4367209</ArticleId>
            <ArticleId IdType="pubmed">25830558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forsythe P., Bienenstock J., Kunze W.A. Vagal pathways for microbiome-brain-gut axis communication. Adv. Exp. Med. Biol. 2014;817:115–133. doi: 10.1007/978-1-4939-0897-4_5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4939-0897-4_5</ArticleId>
            <ArticleId IdType="pubmed">24997031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deretzi G., Kountouras J., Polyzos S.A., Zavos C., Giartza-Taxidou E., Gavalas E., Tsiptsios I. Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases. Curr. Mol. Med. 2011;11:696–707. doi: 10.2174/156652411797536660.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/156652411797536660</ArticleId>
            <ArticleId IdType="pubmed">21902649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deretzi G., Kountouras J., Grigoriadis N., Zavos C., Chatzigeorgiou S., Koutlas E., Tsiptsios I. From the “little brain” gastrointestinal infection to the “big brain” neuroinflammation: A proposed fast axonal transport pathway involved in multiple sclerosis. Med. Hypotheses. 2009;73:781–787. doi: 10.1016/j.mehy.2009.04.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mehy.2009.04.021</ArticleId>
            <ArticleId IdType="pubmed">19467574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doulberis M., Kotronis G., Thomann R., Polyzos S.A., Boziki M., Gialamprinou D., Deretzi G., Katsinelos P., Kountouras J. Review: Impact of Helicobacter pylori on Alzheimer’s disease: What do we know so far? Helicobacter. 2018;23:e12451. doi: 10.1111/hel.12454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/hel.12454</ArticleId>
            <ArticleId IdType="pubmed">29181894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McClain M.S., Cover T.L. Expression of Helicobacter pylori vacuolating toxin in Escherichia coli. Infect Immun. 2003;71:2266–2271. doi: 10.1128/IAI.71.4.2266-2271.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.71.4.2266-2271.2003</ArticleId>
            <ArticleId IdType="pmc">PMC152094</ArticleId>
            <ArticleId IdType="pubmed">12654854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gorlé N., Bauwens E., Haesebrouck F., Smet A., Vandenbroucke R.E. Helicobacter and the Potential Role in Neurological Disorders: There Is More Than Helicobacter pylori. Front. Immunol. 2021;11:584165. doi: 10.3389/fimmu.2020.584165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2020.584165</ArticleId>
            <ArticleId IdType="pmc">PMC7901999</ArticleId>
            <ArticleId IdType="pubmed">33633723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yağci M., Yamaç K., Acar K., Cingi E., Kitapçi M., Haznedar R. Gastric emptying in patients with vitamin B(12) deficiency. Eur. J. Nucl. Med. Mol. Imaging. 2002;29:1125–1127. doi: 10.1007/s00259-002-0854-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00259-002-0854-x</ArticleId>
            <ArticleId IdType="pubmed">12192555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsay F.W., Hsu P.I. H. pylori infection and extra-gastroduodenal diseases. J. Biomed. Sci. 2018;25:65. doi: 10.1186/s12929-018-0469-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12929-018-0469-6</ArticleId>
            <ArticleId IdType="pmc">PMC6114542</ArticleId>
            <ArticleId IdType="pubmed">30157866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller A., Korem M., Almog R., Galboiz Y. Vitamin B12, demyelination, remyelination and repair in multiple sclerosis. J. Neurol. Sci. 2005;233:93–97. doi: 10.1016/j.jns.2005.03.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2005.03.009</ArticleId>
            <ArticleId IdType="pubmed">15896807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yahn G.B., Abato J.E., Jadavji N.M. Role of vitamin B12 deficiency in ischemic stroke risk and outcome. Neural Regen. Res. 2021;16:470–474. doi: 10.4103/1673-5374.291381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/1673-5374.291381</ArticleId>
            <ArticleId IdType="pmc">PMC7996019</ArticleId>
            <ArticleId IdType="pubmed">32985467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Altschuler E. Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischemic neuropathy. Med. Hypotheses. 1996;47:413–414. doi: 10.1016/S0306-9877(96)90223-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0306-9877(96)90223-6</ArticleId>
            <ArticleId IdType="pubmed">8951807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Charlett A., Dobbs R.J., Dobbs S.M., Weller C., Brady P., Peterson D.W. Parkinsonism: Siblings share Helicobacter pylori seropositivity and facets of syndrome. Acta Neurol. Scand. 1999;99:26–35. doi: 10.1111/j.1600-0404.1999.tb00654.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-0404.1999.tb00654.x</ArticleId>
            <ArticleId IdType="pubmed">9925235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bjarnason I.T., Charlett A., Dobbs R.J., Dobbs S.M., Ibrahim M.A., Kerwin R.W., Mahler R.F., Oxlade N.L., Peterson D.W., Plant J.M., et al.  Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: Response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-blind, placebo-controlled efficacy study. Helicobacter. 2005;10:276–287. doi: 10.1111/j.1523-5378.2005.00330.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1523-5378.2005.00330.x</ArticleId>
            <ArticleId IdType="pubmed">16104943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen X., Yang H., Wu Y., Zhang D., Jiang H. Meta-analysis: Association of Helicobacter pylori infection with Parkinson’s diseases. Helicobacter. 2017;22:e12398. doi: 10.1111/hel.12398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/hel.12398</ArticleId>
            <ArticleId IdType="pubmed">28598012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang H.K., Wang J.H., Lei W.Y., Chen C.L., Chang C.Y., Liou L.S. Helicobacter pylori infection is associated with an increased risk of Parkinson’s disease: A population-based retrospective cohort study. Parkinsonism Relat. Disord. 2018;47:26–31. doi: 10.1016/j.parkreldis.2017.11.331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.parkreldis.2017.11.331</ArticleId>
            <ArticleId IdType="pubmed">29174171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gravina A.G., Priadko K., Ciamarra P., Granata L., Facchiano A., Miranda A., Dallio M., Federico A., Romano M. Extra-Gastric Manifestations of Helicobacter pylori Infection. J. Clin. Med. 2020;9:3887.  doi: 10.3390/jcm9123887.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9123887</ArticleId>
            <ArticleId IdType="pmc">PMC7761397</ArticleId>
            <ArticleId IdType="pubmed">33265933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Béraud D., Maguire-Zeiss K.A. Misfolded α-synuclein and Toll-like receptors: Therapeutic targets for Parkinson’s disease. Parkinsonism Relat. Disord. 2012;18((Suppl. S1)):S17–S20. doi: 10.1016/S1353-8020(11)70008-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1353-8020(11)70008-6</ArticleId>
            <ArticleId IdType="pmc">PMC3500631</ArticleId>
            <ArticleId IdType="pubmed">22166424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mridula K.R., Borgohain R., Chandrasekhar Reddy V., Bandaru V., Suryaprabha T. Association of Helicobacter pylori with Parkinson’s Disease. J. Clin. Neurol. (Seoul, Korea) 2017;13:181–186. doi: 10.3988/jcn.2017.13.2.181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3988/jcn.2017.13.2.181</ArticleId>
            <ArticleId IdType="pmc">PMC5392461</ArticleId>
            <ArticleId IdType="pubmed">28406585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fasano A., Bove F., Gabrielli M., Petracca M., Zocco M.A., Ragazzoni E., Barbaro F., Piano C., Fortuna S., Tortora A., et al.  The role of small intestinal bacterial overgrowth in Parkinson’s disease. Mov. Disord. 2013;28:1241–1249. doi: 10.1002/mds.25522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mds.25522</ArticleId>
            <ArticleId IdType="pubmed">23712625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W.S., Yang T.Y., Shen W.C., Lin C.L., Lin M.C., Kao C.H. Association between Helicobacter pylori infection and dementia. J. Clin. Neurosci. 2014;21:1355–1358. doi: 10.1016/j.jocn.2013.11.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jocn.2013.11.018</ArticleId>
            <ArticleId IdType="pubmed">24629396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roubaud Baudron C., Letenneur L., Langlais A., Buissonnière A., Mégraud F., Dartigues J.F., Salles N., Personnes Agées QUID Study  Does Helicobacter pylori infection increase incidence of dementia? The Personnes Agées QUID Study. J. Am. Geriatr. Soc. 2013;61:74–78. doi: 10.1111/jgs.12065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jgs.12065</ArticleId>
            <ArticleId IdType="pubmed">23252507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beydoun M.A., Beydoun H.A., Shroff M.R., Kitner-Triolo M.H., Zonderman A.B. Helicobacter pylori seropositivity and cognitive performance among US adults: Evidence from a large national survey. Psychosom. Med. 2013;75:486–496. doi: 10.1097/PSY.0b013e31829108c3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PSY.0b013e31829108c3</ArticleId>
            <ArticleId IdType="pmc">PMC3679320</ArticleId>
            <ArticleId IdType="pubmed">23697465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kountouras J., Boziki M., Gavalas E., Zavos C., Deretzi G., Grigoriadis N., Tsolaki M., Chatzopoulos D., Katsinelos P., Tzilves D., et al.  Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer’s disease. Int. J. Neurosci. 2009;119:765–777. doi: 10.1080/00207450902782083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00207450902782083</ArticleId>
            <ArticleId IdType="pubmed">19326283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kountouras J., Boziki M., Gavalas E., Zavos C., Deretzi G., Chatzigeorgiou S., Katsinelos P., Grigoriadis N., Giartza-Taxidou E., Venizelos I. Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn. Behav. Neurol. 2010;23:199–204. doi: 10.1097/WNN.0b013e3181df3034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/WNN.0b013e3181df3034</ArticleId>
            <ArticleId IdType="pubmed">20829670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kountouras J., Boziki M., Gavalas E., Zavos C., Grigoriadis N., Deretzi G., Tzilves D., Katsinelos P., Tsolaki M., Chatzopoulos D., et al.  Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease. J. Neurol. 2009;256:758–767. doi: 10.1007/s00415-009-5011-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-009-5011-z</ArticleId>
            <ArticleId IdType="pubmed">19240960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goni E., Franceschi F. Helicobacter pylori and extragastric diseases. Helicobacter. 2016;21((Suppl. S1)):45–48. doi: 10.1111/hel.12340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/hel.12340</ArticleId>
            <ArticleId IdType="pubmed">27531539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang Y.P., Chiu G.F., Kuo F.C., Lai C.L., Yang Y.H., Hu H.M., Chang P.Y., Chen C.Y., Wu D.C., Yu F.J. Eradication of Helicobacter pylori Is Associated with the Progression of Dementia: A PopulationBased Study. Gastroenterol. Res. Pract. 2013;2013:175729. doi: 10.1155/2013/175729.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/175729</ArticleId>
            <ArticleId IdType="pmc">PMC3859120</ArticleId>
            <ArticleId IdType="pubmed">24371435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiota S., Murakami K., Yoshiiwa A., Yamamoto K., Ohno S., Kuroda A., Mizukami K., Hanada K., Okimoto T., Kodama M., et al.  The relationship between Helicobacter pylori infection and Alzheimer’s disease in Japan. J. Neurol. 2011;258:1460–1463. doi: 10.1007/s00415-011-5957-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-011-5957-5</ArticleId>
            <ArticleId IdType="pmc">PMC3742106</ArticleId>
            <ArticleId IdType="pubmed">21336779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santos C.Y., Snyder P.J., Wu W.C., Zhang M., Echeverria A., Alber J. Pathophysiologic relationship between Alzheimer’s disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis. Alzheimers Dement. (Amst.) 2017;7:69–87. doi: 10.1016/j.dadm.2017.01.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.dadm.2017.01.005</ArticleId>
            <ArticleId IdType="pmc">PMC5328683</ArticleId>
            <ArticleId IdType="pubmed">28275702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kira J.-I., Isobe N. Helicobacter pylori infection and demyelinating disease of the central nervous system. J. Neuroimmunol. 2019;329:14–19. doi: 10.1016/j.jneuroim.2018.06.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2018.06.017</ArticleId>
            <ArticleId IdType="pubmed">29983199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebers G.C. Environmental factors and multiple sclerosis. Lancet Neurol. 2008;7:268–277. doi: 10.1016/S1474-4422(08)70042-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(08)70042-5</ArticleId>
            <ArticleId IdType="pubmed">18275928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sand I.K., Zhu Y., Ntranos A., Clemente J.C., Cekanaviciute E., Brandstadter R., Crabtree-Hartman E., Singh S., Bencosme Y., Debelius J., et al.  Disease-modifying therapies alter gut microbial composition in MS. Neurol.-Neuroimmunol. Neuroinflammation. 2018;6:e517. doi: 10.1212/NXI.0000000000000517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000517</ArticleId>
            <ArticleId IdType="pmc">PMC6278850</ArticleId>
            <ArticleId IdType="pubmed">30568995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cossu D., Yokoyama K., Hattori N. Bacteria–host interactions in multiple sclerosis. Front. Microbiol. 2018;9:2966. doi: 10.3389/fmicb.2018.02966.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2018.02966</ArticleId>
            <ArticleId IdType="pmc">PMC6288311</ArticleId>
            <ArticleId IdType="pubmed">30564215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li W., Minohara M., Su J.J., Matsuoka T., Osoegawa M., Ishizu T., Kira J. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J. Neuroimmunol. 2007;184:227–231. doi: 10.1016/j.jneuroim.2006.12.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2006.12.010</ArticleId>
            <ArticleId IdType="pubmed">17296235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cook K.W., Crooks J., Hussain K., O’Brien K., Braitch M., Kareem H., Constantinescu C.S., Robinson K., Gran B. Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis. Front. Microbiol. 2015;6:52. doi: 10.3389/fmicb.2015.00052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2015.00052</ArticleId>
            <ArticleId IdType="pmc">PMC4327743</ArticleId>
            <ArticleId IdType="pubmed">25762984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smyk D.S., Koutsoumpas A.L., Mytilinaiou M.G., Rigopoulou E.I., Sakkas L.I., Bogdanos D.P. Helicobacter pylori and autoimmune disease: Cause or bystander. World J. Gastroenterol. 2014;20:613–629. doi: 10.3748/wjg.v20.i3.613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v20.i3.613</ArticleId>
            <ArticleId IdType="pmc">PMC3921471</ArticleId>
            <ArticleId IdType="pubmed">24574735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ram M., Barzilai O., Shapira Y., Anaya J.-M., Tincani A., Stojanovich L., Bombardieri S., Bizzaro N., Kivity S., Levin N.A., et al.  Helicobacter pylori serology in autoimmune diseases – fact or fiction? Clin. Chem. Lab. Med. 2013;51:1075–1082. doi: 10.1515/cclm-2012-0477.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1515/cclm-2012-0477</ArticleId>
            <ArticleId IdType="pubmed">23079514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Relationship between Helicobacter pylori Infection and Multiple Sclerosis—ScienceOpen n.d.  [(accessed on 23 April 2021)].  Available online:  https://www.scienceopen.com/document?vid=4c548e26-5a70-4735-8991-80c42e3ea4ff.</Citation>
        </Reference>
        <Reference>
          <Citation>Long Y., Gao C., Qiu W., Hu X., Shu Y., Peng F., Lu Z. Helicobacter pyloriInfection in Neuromyelitis Optica and Multiple Sclerosis. Neuroimmunomodulation. 2013;20:107–112. doi: 10.1159/000345838.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000345838</ArticleId>
            <ArticleId IdType="pubmed">23295676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deretzi G., Gavalas E., Boziki M., Tsiptsios D., Polyzos S.A., Venizelos I., Zavos C., Koutlas E., Tsiptsios I., Katsinelos P., et al.  Impact ofHelicobacter pylorion multiple sclerosis-related clinically isolated syndrome. Acta Neurol. Scand. 2015;133:268–275. doi: 10.1111/ane.12453.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ane.12453</ArticleId>
            <ArticleId IdType="pubmed">26079721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerges S.E., Alosh T.K., Khalil S.H., el Din M.M.W. Relevance of Helicobacter pylori infection in Egyptian multiple sclerosis patients. Egypt. J. Neurol. Psychiatry Neurosurg. 2018;54:41. doi: 10.1186/s41983-018-0043-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s41983-018-0043-x</ArticleId>
            <ArticleId IdType="pmc">PMC6290718</ArticleId>
            <ArticleId IdType="pubmed">30595647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fourie K.R., Wilson H.L. Understanding groel and dnak stress response proteins as antigens for bacterial diseases. Vaccines. 2020;8:773.  doi: 10.3390/vaccines8040773.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/vaccines8040773</ArticleId>
            <ArticleId IdType="pmc">PMC7767184</ArticleId>
            <ArticleId IdType="pubmed">33348708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loshaj-Shala A., Regazzoni L., Daci A., Orioli M., Brezovska K., Panovska A.P., Beretta G., Suturkova L. Guillain Barré syndrome (GBS): New insights in the molecular mimicry between C. jejuni and human peripheral nerve (HPN) proteins. J. Neuroimmunol. 2015;289:168–176. doi: 10.1016/j.jneuroim.2015.11.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2015.11.005</ArticleId>
            <ArticleId IdType="pubmed">26616887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elfaitouri A., Herrmann B., Bölin-Wiener A., Wang Y., Gottfries C.-G., Zachrisson O., Pipkorn R., Rönnblom L., Blomberg J. Epitopes of Microbial and Human Heat Shock Protein 60 and Their Recognition in Myalgic Encephalomyelitis. PLoS ONE. 2013;8:e81155.  doi: 10.1371/journal.pone.0081155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0081155</ArticleId>
            <ArticleId IdType="pmc">PMC3842916</ArticleId>
            <ArticleId IdType="pubmed">24312270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiricosta L., Gugliandolo A., Bramanti P., Mazzon E. Could the heat shock proteins 70 family members exacerbate the immune response in multiple sclerosis? An in silico study. Genes. 2020;11:615.  doi: 10.3390/genes11060615.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/genes11060615</ArticleId>
            <ArticleId IdType="pmc">PMC7348765</ArticleId>
            <ArticleId IdType="pubmed">32503176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao G., Wang P., Luo X.D., Yu T.M., Harris R.A., Zhang X.M. Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis. Neurosci. Lett. 2016;620:1–7. doi: 10.1016/j.neulet.2016.03.037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neulet.2016.03.037</ArticleId>
            <ArticleId IdType="pubmed">27033666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pedrini M.J.F., Seewann A., Bennett K.A., Wood A.J.T., James I., Burton J., Marshall B.J., Carroll W.M., Kermode A.G. Helicobacter pyloriinfection as a protective factor against multiple sclerosis risk in females. J. Neurol. Neurosurg. Psychiatry. 2015;86:603–607. doi: 10.1136/jnnp-2014-309495.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2014-309495</ArticleId>
            <ArticleId IdType="pubmed">25602009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohebi N., Mamarabadi M., Moghaddasi M. Relation of Helicobacter pylori infection and multiple sclerosis in Iranian patients. Neurol. Int. 2013;5:31–33. doi: 10.4081/ni.2013.e10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4081/ni.2013.e10</ArticleId>
            <ArticleId IdType="pmc">PMC3718244</ArticleId>
            <ArticleId IdType="pubmed">23888213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kiani S., Vakilian A., Kamiab Z., Shamsizadeh A. Correlation of dietary intake and Helicobacter pylori infection with multiple sclerosis, a case-control study in Rafsanjan, Iran, 2017–2018. Qatar Med. J. 2021;2020:45. doi: 10.5339/qmj.2020.45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5339/qmj.2020.45</ArticleId>
            <ArticleId IdType="pmc">PMC7878158</ArticleId>
            <ArticleId IdType="pubmed">33623753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ranjbar R., Karampoor S., Jalilian F.A. The protective effect of Helicobacter pylori infection on the susceptibility of multiple sclerosis. J. Neuroimmunol. 2019;337:577069. doi: 10.1016/j.jneuroim.2019.577069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2019.577069</ArticleId>
            <ArticleId IdType="pubmed">31610314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robinson K., Stephens J., Constantinescu C.S., Gran B.  Neuro-Immuno-Gastroenterology. Springer International Publishing; Cham, Switzerland: 2016. Helicobacter pylori, experimental autoimmune encephalomyelitis, and multiple sclerosis; pp. 97–122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-3-319-28609-9_6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnold I.C., Hitzler I., Müller A. The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders. Front. Cell. Infect. Microbiol. 2012;2:10. doi: 10.3389/fcimb.2012.00010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2012.00010</ArticleId>
            <ArticleId IdType="pmc">PMC3417532</ArticleId>
            <ArticleId IdType="pubmed">22919602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cook K., Letley D.P., Ingram R.J.M., Staples E., Skjoldmose H., Atherton J.C., Robinson K. CCL20/CCR6-mediated migration of regulatory T cells to theHelicobacter pylori-infected human gastric mucosa. Gut. 2014;63:1550–1559. doi: 10.1136/gutjnl-2013-306253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2013-306253</ArticleId>
            <ArticleId IdType="pmc">PMC4173663</ArticleId>
            <ArticleId IdType="pubmed">24436142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Comerford I., Bunting M., Fenix K., Haylock-Jacobs S., Litchfield W., Harata-Lee Y., Turvey M., Brazzatti J., Gregor C., Nguyen P., et al.  An immune paradox: How can the same chemokine axis regulate both immune tolerance and activation? BioEssays. 2010;32:1067–1076. doi: 10.1002/bies.201000063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/bies.201000063</ArticleId>
            <ArticleId IdType="pubmed">20954179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elhofy A., DePaolo R.W., Lira S.A., Lukacs N.W., Karpus W.J. Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2009;213:91–99. doi: 10.1016/j.jneuroim.2009.05.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2009.05.011</ArticleId>
            <ArticleId IdType="pmc">PMC2728039</ArticleId>
            <ArticleId IdType="pubmed">19535153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liston A., Kohler R.E., Townley S., Haylock-Jacobs S., Comerford I., Caon A.C., Webster J., Harrison J.M., Swann J., Clark-Lewis I., et al.  Inhibition of CCR6 Function Reduces the Severity of Experimental Autoimmune Encephalomyelitis via Effects on the Priming Phase of the Immune Response. J. Immunol. 2009;182:3121–3130. doi: 10.4049/jimmunol.0713169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0713169</ArticleId>
            <ArticleId IdType="pubmed">19234209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willison H.J., Jacobs B.C., van Doorn P.A. Guillain-Barré syndrome. Lancet. 2016;388:717–727. doi: 10.1016/S0140-6736(16)00339-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)00339-1</ArticleId>
            <ArticleId IdType="pubmed">26948435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leonhard S.E., Mandarakas M.R., Gondim F.A.A., Bateman K., Ferreira M.L.B., Cornblath D.R., Van Doorn P.A., Dourado M.E., Hughes R.A.C., Islam B., et al.  Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat. Rev. Neurol. 2019;15:671–683. doi: 10.1038/s41582-019-0250-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41582-019-0250-9</ArticleId>
            <ArticleId IdType="pmc">PMC6821638</ArticleId>
            <ArticleId IdType="pubmed">31541214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao-Lormeau V.-M., Blake A., Mons S., Lastère S., Roche C., Vanhomwegen J., Dub T., Baudouin L., Teissier A., Larre P., et al.  Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: A case-control study. Lancet. 2016;387:1531–1539. doi: 10.1016/S0140-6736(16)00562-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)00562-6</ArticleId>
            <ArticleId IdType="pmc">PMC5444521</ArticleId>
            <ArticleId IdType="pubmed">26948433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van den Berg B., van der Eijk A.A., Pas S.D., Hunter J.G., Madden R.G., Tio-Gillen A.P., Dalton H.R., Jacobs B.C. Guillain-Barré syndrome associated with preceding hepatitis E virus infection. Neurology. 2014;82:491–497. doi: 10.1212/WNL.0000000000000111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000000111</ArticleId>
            <ArticleId IdType="pubmed">24415572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobs B.C., Rothbarth P.H., van der Meché F., Herbrink P., Schmitz P.I., de Klerk M.A., van Doorn P.A. The spectrum of antecedent infections in Guillain-Barré syndrome. Neurology. 1998;51:1110–1115. doi: 10.1212/WNL.51.4.1110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.51.4.1110</ArticleId>
            <ArticleId IdType="pubmed">9781538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimachkie M.M., Barohn R.J. Guillain-Barré syndrome and variants. Neurol. Clin. 2013;31:491–510. doi: 10.1016/j.ncl.2013.01.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ncl.2013.01.005</ArticleId>
            <ArticleId IdType="pmc">PMC3939842</ArticleId>
            <ArticleId IdType="pubmed">23642721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rocha Cabrero F., Morrison E.H.  StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: Apr 28, 2021.  [(accessed on 23 April 2021)]. Miller Fisher Syndrome. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK507717/</Citation>
        </Reference>
        <Reference>
          <Citation>Steer A.C., Starr M., Kornberg A.J. Bickerstaff brainstem encephalitis associated with Mycoplasma pneumoniae infection. J. Child Neurol. 2006;21:533–534. doi: 10.1177/08830738060210061401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/08830738060210061401</ArticleId>
            <ArticleId IdType="pubmed">16948943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ho T.W., Mishu B., Li C.Y., Gao C.Y., Cornblath D.R., Griffin J.W., Asbury A.K., Blaser M.J., McKhann G.M. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Pt 3Brain. 1995;118:597–605. doi: 10.1093/brain/118.3.597.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/118.3.597</ArticleId>
            <ArticleId IdType="pubmed">7600081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hafer-Macko C.E., Sheikh K.A., Li C.Y., Ho T.W., Cornblath D.R., McKhann G.M., Asbury A.K., Griffin J.W. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 1996;39:625–635. doi: 10.1002/ana.410390512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.410390512</ArticleId>
            <ArticleId IdType="pubmed">8619548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kountouras J., Deretzi G., Zavos C., Karatzoglou P., Touloumis L., Nicolaides T., Chatzopoulos D., Venizelos I. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur. J. Neurol. 2005;12:139–143. doi: 10.1111/j.1468-1331.2004.00977.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1468-1331.2004.00977.x</ArticleId>
            <ArticleId IdType="pubmed">15679702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moran A.P., Prendergast M.M. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: Contribution of gastrointestinal infections to autoimmunity. J. Autoimmun. 2001;16:241–256. doi: 10.1006/jaut.2000.0490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/jaut.2000.0490</ArticleId>
            <ArticleId IdType="pubmed">11334489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiba S., Sugiyama T., Yonekura K., Tanaka S., Matsumoto H., Fujii N., Ebisu S., Sekiguchi K. An antibody to VacA of Helicobacter pylori in cerebrospinal fluid from patients with Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry. 2002;73:76–78. doi: 10.1136/jnnp.73.1.76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.73.1.76</ArticleId>
            <ArticleId IdType="pmc">PMC1757281</ArticleId>
            <ArticleId IdType="pubmed">12082053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Álvarez-Arellano L. Helicobacter pylori and neurological diseases: Married by the laws of inflammation. World J. Gastrointest. Pathophysiol. 2014;5:400. doi: 10.4291/wjgp.v5.i4.400.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4291/wjgp.v5.i4.400</ArticleId>
            <ArticleId IdType="pmc">PMC4231504</ArticleId>
            <ArticleId IdType="pubmed">25400983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bickerstaff E.R. Brain-stem Encephalitis. BMJ. 1957;1:1384–1390. doi: 10.1136/bmj.1.5032.1384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.1.5032.1384</ArticleId>
            <ArticleId IdType="pmc">PMC1973653</ArticleId>
            <ArticleId IdType="pubmed">13436795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiba A., Kusunoki S., Shimizu T., Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 1992;31:677–679. doi: 10.1002/ana.410310619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.410310619</ArticleId>
            <ArticleId IdType="pubmed">1514781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuki N., Sato S., Tsuji S., Hozumi I., Miyatake T. An immunologic abnormality common to Bickerstaff’s brain stem encephalitis and Fisher’s syndrome. J. Neurol. Sci. 1993;118:83–87. doi: 10.1016/0022-510X(93)90250-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0022-510X(93)90250-3</ArticleId>
            <ArticleId IdType="pubmed">8229054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Odaka M., Yuki N., Hirata K. Anti-GQ1b IgG antibody syndrome: Clinical and immunological range. J. Neurol. Neurosurg. Psychiatry. 2001;70:50–55. doi: 10.1136/jnnp.70.1.50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.70.1.50</ArticleId>
            <ArticleId IdType="pmc">PMC1763462</ArticleId>
            <ArticleId IdType="pubmed">11118247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tatsumoto M., Koga M., Gilbert M., Odaka M., Hirata K., Kuwabara S., Yuki N. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. J. Neuroimmunol. 2006;177:201–208. doi: 10.1016/j.jneuroim.2006.04.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2006.04.005</ArticleId>
            <ArticleId IdType="pubmed">16844234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ito M., Kuwabara S., Odaka M., Misawa S., Koga M., Hirata K., Yuki N. Bickerstaff’s brainstem encephalitis and Fisher syndrome form a continuous spectrum. J. Neurol. 2008;255:674–682. doi: 10.1007/s00415-008-0775-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-008-0775-0</ArticleId>
            <ArticleId IdType="pubmed">18274803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kountouras J., Deretzi G., Grigoriadis N., Zavos C., Boziki M., Gavalas E., Katsinelos P., Tzilves D., Giouleme O., Lazaraki G. Guillain-Barré syndrome. Lancet Neurol. 2008;7:1080–1081. doi: 10.1016/S1474-4422(08)70247-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(08)70247-3</ArticleId>
            <ArticleId IdType="pubmed">19007730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805–815. doi: 10.1016/S1474-4422(07)70216-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(07)70216-8</ArticleId>
            <ArticleId IdType="pubmed">17706564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wingerchuk D.M., Hogancamp W.F., O’Brien P.C., Weinshenker B.G. The clinical course of neuromyelitis optica (Devic’s syndrome) Neurology. 1999;53:1107–1114. doi: 10.1212/WNL.53.5.1107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.53.5.1107</ArticleId>
            <ArticleId IdType="pubmed">10496275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sellner J., Hemmer B., Mühlau M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J. Autoimmun. 2010;34:371–379. doi: 10.1016/j.jaut.2009.09.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaut.2009.09.013</ArticleId>
            <ArticleId IdType="pubmed">19853412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jarius S., Wildemann B. AQP4 antibodies in neuromyelitis optica: Diagnostic and pathogenetic relevance. Nat. Rev. Neurol. 2010;6:383–392. doi: 10.1038/nrneurol.2010.72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneurol.2010.72</ArticleId>
            <ArticleId IdType="pubmed">20639914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li W., Minohara M., Piao H., Matsushita T., Masaki K., Matsuoka T., Isobe N., Su J.J., Ohyagi Y., Kira J.-I. Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica. Mult. Scler. J. 2009;15:1411–1421. doi: 10.1177/1352458509348961.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1352458509348961</ArticleId>
            <ArticleId IdType="pubmed">19965522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kira J.I. Neuromyelitis optica and opticospinal multiple sclerosis: Mechanisms and pathogenesis. Pathophysiology. 2011;18:69–79. doi: 10.1016/j.pathophys.2010.04.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pathophys.2010.04.008</ArticleId>
            <ArticleId IdType="pubmed">20494560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z.W., Li Y., Huang L.Y., Guan Q.K., Xu D.W., Zhou W.K., Zhang X.Z. Helicobacter pylori infection contributes to high risk of ischemic stroke: Evidence from a meta-analysis. J. Neurol. 2012;259:2527–2537. doi: 10.1007/s00415-012-6558-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-012-6558-7</ArticleId>
            <ArticleId IdType="pubmed">22688569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y., Segers S., Blaser M.J. Association between Helicobacter pylori and mortality in the NHANES III study. Gut. 2013;62:1262–1269. doi: 10.1136/gutjnl-2012-303018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2012-303018</ArticleId>
            <ArticleId IdType="pmc">PMC3834579</ArticleId>
            <ArticleId IdType="pubmed">23303440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franceschi F., Tortora A., Gasbarrini G., Gasbarrini A. Helicobacter pylori and extragastric diseases. Helicobacter. 2014;19((Suppl. S1)):52–58. doi: 10.1111/hel.12159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/hel.12159</ArticleId>
            <ArticleId IdType="pubmed">25167946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tunca A., Türkay C., Tekin O., Kargili A., Erbayrak M. Is Helicobacter pylori infection a risk factor for migraine? A case-control study. Acta Neurol. Belg. 2004;104:161–164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15742606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hosseinzadeh M., Khosravi A., Saki K., Ranjbar R. Evaluation of Helicobacter pylori infection in patients with common migraine headache. Arch. Med. Sci. 2011;7:844–849. doi: 10.5114/aoms.2011.25560.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5114/aoms.2011.25560</ArticleId>
            <ArticleId IdType="pmc">PMC3258796</ArticleId>
            <ArticleId IdType="pubmed">22291830</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
